Repurposing Drugs in Oncology (ReDO)

Repurposing Drugs in Oncology (ReDO) is a research effort that explores using existing medications—originally approved for other health conditions—to treat cancer. Because these drugs have already been tested for safety, they can often be brought into cancer treatment faster and at a lower cost than new drugs. ReDO aims to identify effective, affordable options by examining how these medications might inhibit tumor growth or enhance existing therapies, potentially improving outcomes for patients and expanding available treatment options with known safety profiles.